Altria Group Reports Q3 Adjusted Diluted EPS Of $1.22.

QTRLY TOTAL CIGARETTE SHIPMENT VOLUMES $24.05 BILLION (NOT $24.50 BILLION), DOWN 12.9%.
ALTRIA REPORTS 2021 THIRD-QUARTER AND NINE-MONTHS RESULTS; ANNOUNCES EXPANDED SHARE REPURCHASE PROGRAM; NARROWS 2021 FULL-YEAR EARNINGS GUIDANCE.
RAISES FY ADJUSTED EARNINGS PER SHARE VIEW TO $4.58 TO $4.62.
NARROWS ITS 2021 FULL-YEAR ADJUSTED DILUTED EARNINGS PER SHARE (EPS) GUIDANCE.
Q3 ADJUSTED DILUTED EPS $1.22.
QTRLY LOSS PER SHARE OF $1.48.
Q3 REVENUE $6.79 BILLION DOWN 4.7%.
ALTRIA NARROWS ITS GUIDANCE FOR 2021 FULL-YEAR ADJUSTED DILUTED EPS TO BE IN A RANGE OF $4.58 TO $4.62.
ALTRIA EXPECTS ITS 2021 CAPITAL EXPENDITURES TO BE BETWEEN $150 MILLION AND $200 MILLION.
ALTRIA GROUP -CONTINUE TO MONITOR IMPACT OF COVID-19 ON JUULâ€™S BUSINESS, INCLUDING NEAR-TERM SUPPLY CHAIN CONSTRAINTS AND COMPONENT PART SHORTAGES.
ALTRIA GROUP  - RECORDED A NON-CASH PRE-TAX IMPAIRMENT CHARGE OF APPROXIMATELY $6.2 BILLION FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021.
DURING 2020 & FIRST 9 MONTHS OF 2021, JUUL'S OPERATIONS WERE NEGATIVELY IMPACTED BY COVID-19 PANDEMIC.
ALTRIA GROUP-EXPECTS FY 2021 CAPITAL EXPENDITURES TO BE BETWEEN $150 MILLION AND $200 MILLION, CHANGE FROM ITS PREVIOUS EXPECTATION OF $200 MILLION TO $250 MILLION.
ALTRIA GROUP  - DURING 2020 AND THE FIRST NINE MONTHS OF 2021, CRONOS HAS BEEN ADVERSELY IMPACTED BY THE COVID-19 PANDEMIC.